SAN FRANCISCO--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) reported today that recent work supported by Enzo will be presented at the Liver Conference®, sponsored by the American Society for the Study of Liver Diseases (ASSLD), detailing research advances in understanding Natural Killer cells (NKT cells)
